Peritoneal Carcinoma: Clinical Trials

13 trials for Peritoneal Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 terminated, 2 not yet recruiting, 1 recruiting. 13 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 113Completed 6, Terminated 4, Not yet recruiting 2, Recruiting 1
Phase 24Completed 2, Terminated 2

Follow Peritoneal Carcinoma: new trials by email Literature Review of Peritoneal Carcinoma trials Research Report on Peritoneal Carcinoma

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Supplemental Arginine With Chemotherapy and Immunotherapy in Platinum Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer
(Arginaid®) Oral Arginine, (R-Gene® 10) IV Arginine, Pembrolizumab - Platinum Resistant Ovarian Cancer, Fallopian Tube Cancers
Phase 1Not yet recruitingRebecca Arend242026-09-012026-10-15
SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
SCT-001 CAR-T cells - Ovarian Cancer, Fallopian Tube Carcinoma
Phase 1Not yet recruitingShanghai Gynecologic Oncology Group242025-06-012025-02-26
Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
vvDD-hIL-2-RG-1 - Gastric Neoplasms, Esophageal Cancer
Phase 1RecruitingAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)182025-05-062025-06-03
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
NM32-2668 - Ovarian Carcinoma, Fallopian Tube Carcinoma
Phase 1TerminatedNumab Therapeutics AG112024-05-012025-07-23
Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer
Oxaliplatin, mFOLFIRI - Colorectal Cancer, Appendiceal Cancer
Phase 1TerminatedUniversity of Utah12021-03-222021-09-27
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
NM21-1480 - Advanced Solid Tumor, Non-small Cell Lung Cancer
Phase 1 / Phase 2TerminatedNumab Therapeutics AG522020-08-192025-05-23
Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC
Radspherin - Peritoneal Carcinoma, Colorectal Carcinoma
Phase 1 / Phase 2CompletedOncoinvent Solutions AS472020-05-272025-08-28
A Trial Evaluating TG4050 in Ovarian Carcinoma.
TG4050 - Ovarian Carcinoma, Fallopian Tube Cancer
Phase 1CompletedTransgene642019-12-092025-11-14
Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
ribociclib, Paclitaxel, Carboplatin - Ovarian Cancer, Fallopian Tube Cancer
Phase 1CompletedRonald Buckanovich352017-06-102022-09-07
CAR T Cells in Mesothelin Expressing Cancers
huCART-meso cells - Lung Adenocarcinoma, Ovarian Cancer
Phase 1CompletedUniversity of Pennsylvania652017-04-062025-04-29
Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer
carboplatin - FIGO Stage IIC-IV Ovarian Carcinoma, Fallopian Tube Carcinoma
Phase 1CompletedUniversity of California, Irvine302014-07-012020-01-31
Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer
trientine dihydrochloride, pegylated liposomal doxorubicin, carboplatin - Ovarian Neoplasms Malignant (Excl Germ Cell), Peritoneal Carcinoma
Phase 1 / Phase 2CompletedNational Cheng-Kung University Hospital182012-09-012020-11-10
Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma
Pazopanib, Doxil - Ovarian Cancer, Fallopian Tube Cancer
Phase 1 / Phase 2TerminatedSCRI Development Innovations, LLC222010-01-012021-10-28

Narrower conditions

Fallopian Tube Neoplasms (10)  ·  Ovarian Neoplasms (7)  ·  Colorectal Neoplasms (3)  ·  Adenocarcinoma of Lung (2)  ·  Mesothelioma, Malignant (2)  ·  Triple Negative Breast Neoplasms (2)  ·  Appendiceal Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Squamous Cell (1)  ·  Endometrial Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Leiomyosarcoma (1)

Broader conditions

Neoplasms by Site (13)  ·  Neoplasms (12)  ·  Adnexal Diseases (10)  ·  Fallopian Tube Diseases (10)  ·  Female Urogenital Diseases (10)  ·  Female Urogenital Diseases and Pregnancy Complications (10)  ·  Genital Diseases (10)  ·  Genital Diseases, Female (10)  ·  Genital Neoplasms, Female (10)  ·  Urogenital Diseases (10)  ·  Urogenital Neoplasms (10)  ·  Endocrine Gland Neoplasms (8)  ·  Endocrine System Diseases (8)  ·  Gonadal Disorders (8)  ·  Ovarian Diseases (8)

Interventions

Carboplatin (3)  ·  Paclitaxel (2)  ·  liposomal doxorubicin (2)  ·  Arginine (1)  ·  Bevacizumab (1)  ·  Cyclophosphamide (1)  ·  Dimethoate (1)  ·  Oxaliplatin (1)  ·  Platinum (1)  ·  Trientine (1)  ·  pazopanib (1)  ·  pembrolizumab (1)  ·  ribociclib (1)

Sponsors

Numab Therapeutics AG (2)  ·  Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (1)  ·  National Cheng-Kung University Hospital (1)  ·  Oncoinvent Solutions AS (1)  ·  Rebecca Arend (1)  ·  Ronald Buckanovich (1)  ·  SCRI Development Innovations, LLC (1)  ·  Shanghai Gynecologic Oncology Group (1)  ·  Transgene (1)  ·  University of California, Irvine (1)  ·  University of Pennsylvania (1)  ·  University of Utah (1)

Countries

United States (10)  ·  China (1)  ·  France (1)  ·  Norway (1)  ·  Spain (1)  ·  Sweden (1)  ·  Taiwan (1)

Top investigators

Janos L Tanyi, MD, PhD (1)  ·  Krishnansu Tewari, MD (1)  ·  Lan G Coffman, M.D. (1)  ·  Laura Lambert, MD (1)  ·  Patrick Wagner, MD (1)  ·  Rebecca C Arend, MD (1)  ·  T.Michael Numnum, MD (1)

Results publications

PMID 31179244, PMID 35972817, PMID 36936230, PMID 41424175

NIH funding

2018 (1)